Cian Healthcare Limited (BOM:542678)
India
· Delayed Price · Currency is INR 3.240
+0.060 (1.89%)
At close: May 5, 2025
Cian Healthcare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2016 - 2019 |
| Operating Revenue | 479.79 | 616.96 | 685.9 | 778.7 | 737.3 | 570.88 | Upgrade
|
| Other Revenue | 1.97 | 1.97 | 0.86 | 1.95 | 2.1 | 2.41 | Upgrade
|
| Revenue | 481.76 | 618.92 | 686.76 | 780.66 | 739.41 | 573.29 | Upgrade
|
| Revenue Growth (YoY) | -24.05% | -9.88% | -12.03% | 5.58% | 28.98% | -9.57% | Upgrade
|
| Cost of Revenue | 248.25 | 313.51 | 340.88 | 486.5 | 408.95 | 341.83 | Upgrade
|
| Gross Profit | 233.5 | 305.41 | 345.88 | 294.16 | 330.46 | 231.47 | Upgrade
|
| Selling, General & Admin | 91.17 | 97.76 | 101.31 | 104.48 | 77.63 | 48.82 | Upgrade
|
| Other Operating Expenses | 88.63 | 94.99 | 113.81 | 144.06 | 130.84 | 106.78 | Upgrade
|
| Operating Expenses | 231.56 | 247.41 | 269.43 | 291.29 | 243 | 200.09 | Upgrade
|
| Operating Income | 1.95 | 58 | 76.45 | 2.86 | 87.46 | 31.38 | Upgrade
|
| Interest Expense | -48.58 | -55.26 | -57.83 | -61.64 | -75.44 | -71.14 | Upgrade
|
| Interest & Investment Income | 0.99 | 0.99 | 1.41 | 1.61 | 1.93 | 1.82 | Upgrade
|
| Currency Exchange Gain (Loss) | 1.39 | 1.39 | 3.75 | 1.68 | -1.25 | 4.32 | Upgrade
|
| Other Non Operating Income (Expenses) | -6.48 | -4.64 | -5.02 | -3.8 | -3.73 | -0.95 | Upgrade
|
| EBT Excluding Unusual Items | -50.74 | 0.48 | 18.77 | -59.3 | 8.97 | -34.57 | Upgrade
|
| Other Unusual Items | -120.47 | 0.04 | 1.14 | -0.73 | -2.1 | -0.68 | Upgrade
|
| Pretax Income | -171.21 | 0.52 | 19.91 | -60.03 | 6.87 | -35.24 | Upgrade
|
| Income Tax Expense | -6.03 | -2.02 | -0.39 | -4.7 | 6.34 | 2.63 | Upgrade
|
| Net Income | -165.19 | 2.54 | 20.3 | -55.34 | 0.53 | -37.88 | Upgrade
|
| Net Income to Common | -165.19 | 2.54 | 20.3 | -55.34 | 0.53 | -37.88 | Upgrade
|
| Net Income Growth | - | -87.47% | - | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 25 | 25 | 25 | 25 | 27 | 23 | Upgrade
|
| Shares Outstanding (Diluted) | 25 | 25 | 25 | 25 | 27 | 23 | Upgrade
|
| Shares Change (YoY) | 0.01% | - | - | -5.85% | 13.65% | 36.25% | Upgrade
|
| EPS (Basic) | -6.61 | 0.10 | 0.81 | -2.21 | 0.02 | -1.62 | Upgrade
|
| EPS (Diluted) | -6.61 | 0.10 | 0.81 | -2.21 | 0.02 | -1.62 | Upgrade
|
| EPS Growth | - | -87.65% | - | - | - | - | Upgrade
|
| Free Cash Flow | 113.07 | 107.85 | 35.16 | -87.4 | 44.62 | -269.16 | Upgrade
|
| Free Cash Flow Per Share | 4.52 | 4.32 | 1.41 | -3.50 | 1.68 | -11.52 | Upgrade
|
| Gross Margin | 48.47% | 49.35% | 50.36% | 37.68% | 44.69% | 40.38% | Upgrade
|
| Operating Margin | 0.40% | 9.37% | 11.13% | 0.37% | 11.83% | 5.47% | Upgrade
|
| Profit Margin | -34.29% | 0.41% | 2.96% | -7.09% | 0.07% | -6.61% | Upgrade
|
| Free Cash Flow Margin | 23.47% | 17.43% | 5.12% | -11.20% | 6.03% | -46.95% | Upgrade
|
| EBITDA | 53.71 | 112.67 | 130.76 | 45.61 | 121.99 | 75.87 | Upgrade
|
| EBITDA Margin | 11.15% | 18.20% | 19.04% | 5.84% | 16.50% | 13.23% | Upgrade
|
| D&A For EBITDA | 51.77 | 54.67 | 54.31 | 42.75 | 34.53 | 44.49 | Upgrade
|
| EBIT | 1.95 | 58 | 76.45 | 2.86 | 87.46 | 31.38 | Upgrade
|
| EBIT Margin | 0.40% | 9.37% | 11.13% | 0.37% | 11.83% | 5.47% | Upgrade
|
| Effective Tax Rate | - | - | - | - | 92.27% | - | Upgrade
|
| Revenue as Reported | 482.35 | 621.36 | 692.08 | 784.07 | 740.11 | 579.51 | Upgrade
|
| Advertising Expenses | - | 8.53 | 2.26 | 1.78 | 2.74 | 0.81 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.